It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2012
  5. Mucosta® ophthalmic suspension UD2% releases on January 5, 2012

January 5, 2012

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

Mucosta® ophthalmic suspension UD2% releases on January 5, 2012

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced the launch of Mucosta ophthalmic suspension UD 2% for patients with dry eye diagnosed on January 5, 2012 in Japan.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases